About: COVID-19 pandemic: Response plan by the Johns Hopkins Aramco Healthcare inpatient pharmacy department

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: COVID-19 pandemic: Response plan by the Johns Hopkins Aramco Healthcare inpatient pharmacy department Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	COVID-19 pandemic: Response plan by the Johns Hopkins Aramco Healthcare inpatient pharmacy department
Creator	Healthcare, Aramco Hopkins, Johns Pharm, M Pharm, Al Ghamdi, Hamed Arain, Savera Fuad, ; Ghamdi, Al Hamed, Fuad Thalapparambath, Rajesh
source	Elsevier; Medline; PMC
abstract	The coronavirus disease 2019 (COVID-19) is an ongoing pandemic having caused a major health care crises across the globe.Pharmacy professionals are considered vital in preparation for optimal response to the COVID-19 pandemic. Therefore, in response to the estimated potential impact of COVID-19 on Johns Hopkins Aramco Healthcare (joint venture between Saudi Aramco and Johns Hopkins Medicine International), several initiatives were taken by the hospital's inpatient pharmacy department with focus on infection control, staffing, meeting clinical operational challenges, ethics, increased utilization of automation, and maintenance of employee wellness to prepare for this challenge. The plan implemented by the inpatient pharmacy department was prepared while incorporating information and recommendations from leading pharmacy organizations, ministry of health, institute's experience in battling another similar coronavirus (the Middle East respiratory syndrome–coronavirus) previously, and updated scientific research. The key focus areas include development of an institutionalized COVID-19 protocol, measures to improve infection control when handling and dispensing medications, modified staffing plan, system changes in peri-operative areas, keeping pharmacy professionals updated about new and scientific researches, increased utilization of automation, clinical interventions by pharmacist ensuring appropriate utilization of medications while monitoring for drug-drug interactions, adverse drug event prevention, and preparing for handling drug shortages. By implementing a robust plan, pharmacy professionals continue to show that they are an integral member of inter-professional health care teams.
has issue date	2020-05-18(xsd:dateTime)
bibo:doi	10.1016/j.sapharm.2020.05.016
bibo:pmid	32425713
has license	no-cc
sha1sum (hex)	b4fafe6eeaa973831f1b0b031abbfe9d68e000a2
schema:url	https://doi.org/10.1016/j.sapharm.2020.05.016
resource representing a document's title	COVID-19 pandemic: Response plan by the Johns Hopkins Aramco Healthcare inpatient pharmacy department
has PubMed Central identifier	PMC7233240
has PubMed identifier	32425713
schema:publication	Res Social Adm Pharm
resource representing a document's body	covid:b4fafe6eeaa973831f1b0b031abbfe9d68e000a2#body_text
is schema:about of	named entity 'inpatient' named entity 'member' named entity 'Medicine' named entity 'initiatives' named entity 'scientific' named entity 'infection control' named entity 'respiratory' named entity 'drug-drug interactions' named entity 'COVID-19' named entity 'intensive care units' named entity 'pharmacy' named entity 'barcode scanners' named entity 'pharmacy' named entity 'double check' named entity 'pharmacy' named entity 'corticosteroids' named entity 'cardiac catheterization' named entity 'Saudi Aramco' named entity 'medication dispensing' named entity 'neuromuscular blockers' named entity 'infection control' named entity 'clinical pharmacist' named entity 'computerized physician order entry' named entity 'pharmacy' named entity 'measures' named entity 'medications' named entity 'Aramco' named entity 'pharmacy' named entity 'joint venture' named entity 'pharmacy' named entity 'employee wellness' named entity 'infection control' named entity 'Johns Hopkins Medicine International' named entity 'coronavirus' named entity 'ethics' named entity 'drug-drug interactions' named entity 'pharmacist' named entity 'COVID-19 Pandemic' named entity 'Johns Hopkins Aramco Healthcare' named entity 'rapid sequence intubation' named entity 'Pharmacy' named entity 'pharmacy' named entity 'pharmacy' named entity 'challenging times' named entity 'Computerized physician order entry' named entity 'lopinavir/ritonavir' named entity 'multidisciplinary team' named entity 'infection control' named entity 'pharmacist' named entity 'pharmacy' named entity 'COVID-19' named entity 'health care' named entity 'personal protective equipment (PPE' named entity 'pharmacy' named entity 'patient care' named entity 'pharmacy' named entity 'business continuity plan' named entity 'infection control' named entity 'COVID-19' named entity 'hydroxychloroquine' named entity 'pharmacist' named entity 'hydroxychloroquine' named entity 'scientific and research' named entity 'pharmacy' named entity 'health care' named entity 'joint venture' named entity 'COVID-19' named entity 'pharmacy' named entity 'pharmacy' named entity 'outpatient procedure' named entity 'Johns Hopkins Aramco Healthcare' named entity 'COVID-19'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software